| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.962 | 0.002 | 0.962 | Topoisomerase II inhibitor | 0.623 0.004 DBMET03411 0.924 0.002 DBMET03404 0.623 0.004 DBMET03406 0.749 0.003 DBMET03405 0.595 0.005 DBMET03408 0.662 0.004 DBMET03407 0.587 0.005 DBMET03409 0.55 0.005 DBMET03410 | ||
| 0.943 | 0.002 | 0.943 | DNA intercalator | 0.507 0.005 DBMET03411 0.874 0.002 DBMET03404 0.507 0.005 DBMET03406 0.702 0.004 DBMET03405 0.44 0.006 DBMET03408 0.565 0.005 DBMET03407 0.502 0.005 DBMET03409 0.378 0.008 DBMET03410 | ||
| 0.933 | 0.001 | 0.933 | Topoisomerase II alpha inhibitor | 0.502 0.004 DBMET03411 0.885 0.002 DBMET03404 0.502 0.004 DBMET03406 0.67 0.003 DBMET03405 0.47 0.004 DBMET03408 0.554 0.004 DBMET03407 0.381 0.005 DBMET03409 0.42 0.004 DBMET03410 | ||
| 0.932 | 0.001 | 0.932 | DNA repair enzyme inhibitor | 0.193 0.01 DBMET03411 0.765 0.001 DBMET03404 0.193 0.01 DBMET03406 0.23 0.006 DBMET03405 0.328 0.004 DBMET03408 0.187 0.011 DBMET03407 0.144 0.037 DBMET03409 0.197 0.009 DBMET03410 | ||
| 0.932 | 0.002 | 0.932 | DNA damaging | 0.413 0.026 DBMET03411 0.854 0.003 DBMET03404 0.413 0.026 DBMET03406 0.486 0.015 DBMET03405 0.477 0.016 DBMET03408 0.413 0.026 DBMET03407 0.223 0.098 DBMET03409 0.258 0.076 DBMET03410 | ||
| 0.895 | 0.001 | 0.909 | Alkylator | 0.526 0.004 DBMET03411 0.909 0.001 DBMET03404 0.526 0.004 DBMET03406 0.661 0.003 DBMET03405 0.602 0.004 DBMET03408 0.552 0.004 DBMET03407 0.55 0.004 DBMET03409 0.545 0.004 DBMET03410 | DBMET03404 | |
| 0.891 | 0.001 | 0.891 | Antineoplastic antibiotic | 0.61 0.003 DBMET03411 0.846 0.002 DBMET03404 0.61 0.003 DBMET03406 0.74 0.002 DBMET03405 0.524 0.004 DBMET03408 0.677 0.003 DBMET03407 0.581 0.003 DBMET03409 0.568 0.003 DBMET03410 | ||
| 0.87 | 0.002 | 0.87 | DNA synthesis inhibitor | 0.363 0.028 DBMET03411 0.785 0.003 DBMET03404 0.363 0.028 DBMET03406 0.431 0.018 DBMET03405 0.5 0.013 DBMET03408 0.422 0.019 DBMET03407 0.294 0.046 DBMET03409 0.471 0.016 DBMET03410 | ||
| 0.867 | 0 | 0.867 | Antibiotic Anthracycline-like | 0.096 0.001 DBMET03411 0.818 0 DBMET03404 0.096 0.001 DBMET03406 0.191 0 DBMET03405 0.13 0 DBMET03408 0.083 0.001 DBMET03407 0.043 0.002 DBMET03409 0.096 0.001 DBMET03410 | ||
| 0.843 | 0.003 | 0.861 | Antibacterial | 0.605 0.018 DBMET03411 0.861 0.002 DBMET03404 0.605 0.018 DBMET03406 0.673 0.011 DBMET03405 0.685 0.01 DBMET03408 0.639 0.014 DBMET03407 0.714 0.008 DBMET03409 0.682 0.01 DBMET03410 | DBMET03404 | |
| 0.837 | 0.011 | 0.837 | Transcription factor NF kappa B inhibitor | 0.481 0.047 DBMET03411 0.696 0.021 DBMET03404 0.481 0.047 DBMET03406 0.586 0.033 DBMET03405 0.707 0.02 DBMET03408 0.474 0.048 DBMET03407 0.303 0.092 DBMET03409 0.56 0.036 DBMET03410 | ||
| 0.784 | 0.019 | 0.97 | Apoptosis agonist | 0.524 0.067 DBMET03411 0.688 0.033 DBMET03404 0.524 0.067 DBMET03406 0.607 0.048 DBMET03405 0.634 0.042 DBMET03408 0.542 0.062 DBMET03407 0.426 0.102 DBMET03409 0.97 0.004 DBMET03410 | DBMET03410 | |
| 0.768 | 0.004 | 0.768 | Hypoxia-inducible factor 1 alpha inhibitor | 0.487 0.016 DBMET03411 0.602 0.007 DBMET03404 0.487 0.016 DBMET03406 0.455 0.019 DBMET03405 0.448 0.02 DBMET03408 0.447 0.021 DBMET03407 0.239 0.111 DBMET03409 0.263 0.089 DBMET03410 | ||
| 0.664 | 0.002 | 0.664 | Expectorant | 0.217 0.017 DBMET03411 0.643 0.002 DBMET03404 0.217 0.017 DBMET03406 0.27 0.011 DBMET03405 0.394 0.005 DBMET03408 0.188 0.023 DBMET03407 0.092 0.078 DBMET03409 0.272 0.01 DBMET03410 | ||
| 0.596 | 0.002 | 0.596 | Mucolytic | 0.2 0.013 DBMET03411 0.555 0.002 DBMET03404 0.2 0.013 DBMET03406 0.234 0.008 DBMET03405 0.18 0.019 DBMET03408 0.186 0.017 DBMET03407 0.109 0.066 DBMET03409 0.131 0.045 DBMET03410 | ||
| 0.589 | 0.004 | 0.589 | Transcription factor STAT inhibitor | 0.22 0.112 DBMET03411 0.402 0.018 DBMET03404 0.22 0.112 DBMET03406 0.346 0.036 DBMET03405 0.267 0.076 DBMET03407 | ||
| 0.525 | 0.004 | 0.525 | Topoisomerase I inhibitor | 0.3 0.011 DBMET03411 0.459 0.004 DBMET03404 0.3 0.011 DBMET03406 0.368 0.007 DBMET03405 0.351 0.008 DBMET03408 0.338 0.008 DBMET03407 0.287 0.012 DBMET03409 0.312 0.01 DBMET03410 | ||
| 0.515 | 0.007 | 0.515 | P-glycoprotein inhibitor | 0.284 0.032 DBMET03411 0.401 0.016 DBMET03404 0.284 0.032 DBMET03406 0.437 0.013 DBMET03405 0.212 0.057 DBMET03408 0.258 0.039 DBMET03407 0.159 0.103 DBMET03410 | ||
| 0.489 | 0.004 | 0.506 | Protein kinase stimulant | 0.307 0.016 DBMET03411 0.506 0.004 DBMET03404 0.307 0.016 DBMET03406 0.43 0.006 DBMET03405 0.33 0.013 DBMET03408 0.273 0.021 DBMET03407 0.249 0.027 DBMET03410 | DBMET03404 | |
| 0.479 | 0.002 | 0.479 | Topoisomerase II beta inhibitor | 0.097 0.01 DBMET03411 0.424 0.002 DBMET03404 0.097 0.01 DBMET03406 0.126 0.006 DBMET03405 0.055 0.026 DBMET03408 0.129 0.006 DBMET03407 | ||
| 0.475 | 0.007 | 0.475 | DNA methylase inhibitor | 0.291 0.03 DBMET03404 0.176 0.096 DBMET03405 0.217 0.069 DBMET03408 | ||
| 0.48 | 0.023 | 0.483 | Caspase 3 stimulant | 0.37 0.053 DBMET03411 0.419 0.039 DBMET03404 0.37 0.053 DBMET03406 0.483 0.023 DBMET03405 0.431 0.035 DBMET03408 0.332 0.065 DBMET03407 0.304 0.077 DBMET03410 | DBMET03405 | |
| 0.453 | 0.046 | 0.484 | Immunosuppressant | 0.441 0.049 DBMET03411 0.48 0.038 DBMET03404 0.441 0.049 DBMET03406 0.451 0.047 DBMET03405 0.469 0.041 DBMET03408 0.475 0.04 DBMET03407 0.421 0.056 DBMET03409 0.484 0.037 DBMET03410 | DBMET03410 | |
| 0.41 | 0.003 | 0.41 | Transcription factor STAT6 inhibitor | 0.11 0.081 DBMET03411 0.232 0.005 DBMET03404 0.11 0.081 DBMET03406 0.131 0.043 DBMET03405 0.145 0.027 DBMET03407 | ||
| 0.376 | 0 | 0.376 | Ca2+-transporting ATPase inhibitor | 0.211 0.003 DBMET03411 0.327 0 DBMET03404 0.211 0.003 DBMET03406 0.236 0.002 DBMET03405 0.206 0.003 DBMET03408 0.214 0.003 DBMET03407 0.165 0.017 DBMET03409 0.193 0.004 DBMET03410 | ||
| 0.362 | 0.01 | 0.383 | Peptidyltransferase inhibitor | 0.261 0.044 DBMET03411 0.383 0.008 DBMET03404 0.261 0.044 DBMET03406 0.275 0.035 DBMET03405 0.355 0.011 DBMET03408 0.297 0.025 DBMET03407 0.216 0.081 DBMET03409 0.369 0.009 DBMET03410 | DBMET03404 | |
| 0.37 | 0.021 | 0.391 | RNA-directed DNA polymerase inhibitor | 0.257 0.045 DBMET03411 0.279 0.037 DBMET03404 0.257 0.045 DBMET03406 0.238 0.058 DBMET03405 0.213 0.082 DBMET03408 0.294 0.033 DBMET03407 0.391 0.019 DBMET03409 | DBMET03409 | |
| 0.393 | 0.051 | 0.523 | Antithrombotic | 0.271 0.11 DBMET03411 0.464 0.035 DBMET03404 0.271 0.11 DBMET03406 0.288 0.096 DBMET03405 0.523 0.026 DBMET03408 0.294 0.092 DBMET03407 0.467 0.034 DBMET03409 0.446 0.039 DBMET03410 | DBMET03408 | |
| 0.315 | 0.005 | 0.39 | Cyclooxygenase 3 inhibitor | 0.206 0.017 DBMET03411 0.39 0.004 DBMET03404 0.206 0.017 DBMET03406 0.267 0.008 DBMET03405 0.354 0.005 DBMET03408 0.208 0.016 DBMET03407 0.262 0.008 DBMET03410 | DBMET03404 | |
| 0.326 | 0.019 | 0.558 | Melanin inhibitor | 0.558 0.005 DBMET03411 0.447 0.009 DBMET03404 0.558 0.005 DBMET03406 0.527 0.006 DBMET03405 0.539 0.005 DBMET03408 0.516 0.006 DBMET03407 0.174 0.056 DBMET03409 0.455 0.009 DBMET03410 | DBMET03406 | |
| 0.336 | 0.05 | 0.489 | Antioxidant | 0.293 0.064 DBMET03411 0.304 0.06 DBMET03404 0.293 0.064 DBMET03406 0.347 0.047 DBMET03405 0.489 0.021 DBMET03408 0.33 0.052 DBMET03407 0.398 0.035 DBMET03409 0.438 0.029 DBMET03410 | DBMET03408 | |
| 0.301 | 0.021 | 0.346 | Lipocortins synthesis antagonist | 0.323 0.017 DBMET03411 0.323 0.017 DBMET03406 0.203 0.054 DBMET03405 0.271 0.027 DBMET03408 0.346 0.014 DBMET03407 0.26 0.03 DBMET03409 0.263 0.029 DBMET03410 | DBMET03407 | |
| 0.237 | 0.007 | 0.281 | HIV-1 integrase (Strand Transfer) inhibitor | 0.086 0.028 DBMET03411 0.122 0.016 DBMET03404 0.086 0.028 DBMET03406 0.115 0.018 DBMET03405 0.069 0.036 DBMET03408 0.109 0.019 DBMET03407 0.281 0.005 DBMET03409 0.052 0.048 DBMET03410 | DBMET03409 | |
| 0.259 | 0.041 | 0.389 | Hepatoprotectant | 0.235 0.048 DBMET03411 0.252 0.043 DBMET03404 0.235 0.048 DBMET03406 0.275 0.037 DBMET03405 0.389 0.014 DBMET03408 0.262 0.04 DBMET03407 0.276 0.037 DBMET03409 0.363 0.017 DBMET03410 | DBMET03408 | |
| 0.223 | 0.006 | 0.223 | Multidrug resistance-associated protein 1 inhibitor | 0.096 0.085 DBMET03411 0.167 0.019 DBMET03404 0.096 0.085 DBMET03406 0.141 0.03 DBMET03405 0.127 0.041 DBMET03408 0.212 0.008 DBMET03409 0.093 0.092 DBMET03410 | ||
| 0.274 | 0.059 | 0.475 | Angiogenesis stimulant | 0.257 0.067 DBMET03404 0.475 0.013 DBMET03408 0.372 0.027 DBMET03409 0.451 0.015 DBMET03410 | DBMET03408 | |
| 0.221 | 0.008 | 0.27 | HIV-1 integrase (3'-Processing) inhibitor | 0.094 0.028 DBMET03411 0.128 0.017 DBMET03404 0.094 0.028 DBMET03406 0.124 0.018 DBMET03405 0.074 0.037 DBMET03408 0.119 0.019 DBMET03407 0.27 0.005 DBMET03409 0.059 0.048 DBMET03410 | DBMET03409 | |
| 0.271 | 0.06 | 0.414 | Free radical scavenger | 0.227 0.079 DBMET03411 0.247 0.07 DBMET03404 0.227 0.079 DBMET03406 0.264 0.063 DBMET03405 0.414 0.026 DBMET03408 0.258 0.065 DBMET03407 0.183 0.111 DBMET03409 0.356 0.038 DBMET03410 | DBMET03408 | |
| 0.259 | 0.049 | 0.381 | Nitric oxide antagonist | 0.247 0.052 DBMET03411 0.248 0.052 DBMET03404 0.247 0.052 DBMET03406 0.278 0.045 DBMET03405 0.381 0.028 DBMET03408 0.26 0.049 DBMET03407 0.193 0.07 DBMET03409 0.34 0.033 DBMET03410 | DBMET03408 | |
| 0.282 | 0.098 | 0.326 | Apoptosis antagonist | 0.278 0.102 DBMET03404 0.262 0.116 DBMET03405 0.326 0.069 DBMET03408 0.197 0.183 DBMET03407 0.274 0.105 DBMET03410 | DBMET03408 | |
| 0.352 | 0.171 | 0.956 | Antiinflammatory | 0.262 0.253 DBMET03411 0.29 0.225 DBMET03404 0.262 0.253 DBMET03406 0.868 0.008 DBMET03408 0.318 0.198 DBMET03407 0.409 0.134 DBMET03409 0.956 0.004 DBMET03410 | DBMET03410 | |
| 0.213 | 0.036 | 0.385 | Interferon gamma antagonist | 0.251 0.028 DBMET03411 0.167 0.06 DBMET03404 0.251 0.028 DBMET03406 0.199 0.041 DBMET03405 0.385 0.011 DBMET03408 0.274 0.024 DBMET03407 0.326 0.017 DBMET03410 | DBMET03408 | |
| 0.176 | 0.006 | 0.176 | Thioredoxin reductase inhibitor | 0.116 0.019 DBMET03411 0.148 0.01 DBMET03404 0.116 0.019 DBMET03406 0.143 0.011 DBMET03405 0.092 0.038 DBMET03408 0.117 0.018 DBMET03407 0.078 0.067 DBMET03409 0.077 0.071 DBMET03410 | ||
| 0.18 | 0.013 | 0.209 | Selectin antagonist | 0.187 0.013 DBMET03404 0.209 0.01 DBMET03408 0.134 0.02 DBMET03409 0.206 0.01 DBMET03410 | DBMET03408 | |
| 0.171 | 0.005 | 0.174 | Protein 50S ribosomal subunit inhibitor | 0.174 0.005 DBMET03404 0.064 0.028 DBMET03405 0.084 0.018 DBMET03408 0.081 0.019 DBMET03410 | DBMET03404 | |
| 0.239 | 0.076 | 0.276 | Vasodilator | 0.215 0.093 DBMET03411 0.202 0.103 DBMET03404 0.215 0.093 DBMET03406 0.216 0.092 DBMET03405 0.276 0.057 DBMET03408 0.194 0.109 DBMET03407 0.191 0.112 DBMET03410 | DBMET03408 | |
| 0.202 | 0.044 | 0.272 | Amylase inhibitor | 0.179 0.052 DBMET03411 0.234 0.033 DBMET03404 0.179 0.052 DBMET03406 0.153 0.063 DBMET03405 0.272 0.023 DBMET03408 0.204 0.043 DBMET03407 0.187 0.049 DBMET03410 | DBMET03408 | |
| 0.195 | 0.044 | 0.195 | Interleukin 6 antagonist | 0.179 0.055 DBMET03404 0.15 0.089 DBMET03408 | ||
| 0.167 | 0.03 | 0.173 | Microtubule formation inhibitor | 0.132 0.049 DBMET03411 0.173 0.028 DBMET03404 0.132 0.049 DBMET03406 0.157 0.034 DBMET03405 0.15 0.037 DBMET03408 0.119 0.062 DBMET03407 0.108 0.077 DBMET03410 | DBMET03404 | |
| 0.213 | 0.091 | 0.367 | Antiamyloidogenic | 0.343 0.04 DBMET03411 0.202 0.098 DBMET03404 0.343 0.04 DBMET03406 0.367 0.035 DBMET03405 0.308 0.049 DBMET03408 0.286 0.056 DBMET03407 | DBMET03405 | |
| 0.238 | 0.125 | 0.238 | Immunomodulator | |||
| 0.302 | 0.191 | 0.744 | Caspase 9 stimulant | 0.675 0.027 DBMET03411 0.335 0.159 DBMET03404 0.675 0.027 DBMET03406 0.596 0.037 DBMET03405 0.744 0.019 DBMET03408 0.627 0.033 DBMET03407 0.478 0.069 DBMET03410 | DBMET03408 | |
| 0.22 | 0.109 | 0.335 | Immunostimulant | 0.241 0.1 DBMET03404 0.335 0.069 DBMET03408 0.165 0.143 DBMET03407 0.26 0.092 DBMET03409 0.297 0.079 DBMET03410 | DBMET03408 | |
| 0.107 | 0.003 | 0.107 | Antibiotic Aminoglycoside-like | 0.106 0.003 DBMET03404 0.035 0.026 DBMET03405 0.061 0.008 DBMET03408 0.034 0.029 DBMET03407 0.061 0.008 DBMET03410 | ||
| 0.106 | 0.003 | 0.106 | Protein 30S ribosomal subunit inhibitor | 0.029 0.013 DBMET03411 0.103 0.003 DBMET03404 0.029 0.013 DBMET03406 0.03 0.013 DBMET03405 0.063 0.005 DBMET03408 0.049 0.008 DBMET03407 0.062 0.006 DBMET03410 | ||
| 0.146 | 0.053 | 0.164 | Interleukin 4 antagonist | 0.145 0.054 DBMET03411 0.164 0.039 DBMET03404 0.145 0.054 DBMET03406 0.136 0.064 DBMET03405 0.142 0.058 DBMET03408 0.164 0.038 DBMET03407 0.117 0.09 DBMET03410 | DBMET03407 | |
| 0.121 | 0.042 | 0.149 | Toll-Like receptor 4 antagonist | 0.101 0.068 DBMET03411 0.091 0.087 DBMET03404 0.101 0.068 DBMET03406 0.149 0.022 DBMET03408 0.09 0.088 DBMET03407 0.131 0.033 DBMET03410 | DBMET03408 | |
| 0.083 | 0.005 | 0.083 | Motilin receptor agonist | 0.076 0.005 DBMET03404 | ||
| 0.107 | 0.031 | 0.111 | ATPase (Vacuolar H+) inhibitor | 0.082 0.073 DBMET03411 0.111 0.027 DBMET03404 0.082 0.073 DBMET03406 0.093 0.051 DBMET03405 0.098 0.042 DBMET03408 0.082 0.073 DBMET03410 | DBMET03404 | |
| 0.188 | 0.112 | 0.189 | Nitric-oxide synthase stimulant | 0.179 0.131 DBMET03404 0.189 0.11 DBMET03407 | DBMET03407 | |
| 0.119 | 0.057 | 0.158 | Estrogen antagonist | 0.134 0.034 DBMET03411 0.134 0.034 DBMET03406 0.126 0.045 DBMET03405 0.106 0.085 DBMET03408 0.158 0.02 DBMET03407 0.126 0.045 DBMET03409 | DBMET03407 | |
| 0.138 | 0.077 | 0.277 | Lipid peroxidase inhibitor | 0.219 0.034 DBMET03411 0.137 0.078 DBMET03404 0.219 0.034 DBMET03406 0.201 0.041 DBMET03405 0.277 0.022 DBMET03408 0.253 0.026 DBMET03407 0.219 0.034 DBMET03409 0.237 0.03 DBMET03410 | DBMET03408 | |
| 0.071 | 0.015 | 0.071 | Glucose-6-phosphate translocase inhibitor | 0.055 0.029 DBMET03405 0.063 0.021 DBMET03408 0.051 0.036 DBMET03410 | ||
| 0.059 | 0.004 | 0.066 | Ceramide glucosyltransferase inhibitor | 0.066 0.004 DBMET03404 0.043 0.013 DBMET03405 0.034 0.028 DBMET03407 0.033 0.029 DBMET03409 | DBMET03404 | |
| 0.07 | 0.021 | 0.076 | Lipocortins synthesis agonist | 0.07 0.021 DBMET03411 0.07 0.021 DBMET03406 0.06 0.035 DBMET03405 0.076 0.016 DBMET03408 0.074 0.018 DBMET03407 0.068 0.024 DBMET03409 0.076 0.016 DBMET03410 | DBMET03410 | |
| 0.109 | 0.066 | 0.109 | Chelator | 0.099 0.078 DBMET03407 | ||
| 0.111 | 0.068 | 0.309 | Monophenol monooxygenase inhibitor | 0.217 0.029 DBMET03411 0.091 0.083 DBMET03404 0.217 0.029 DBMET03406 0.163 0.042 DBMET03405 0.309 0.017 DBMET03408 0.228 0.027 DBMET03407 0.139 0.051 DBMET03409 0.193 0.035 DBMET03410 | DBMET03408 | |
| 0.104 | 0.073 | 0.227 | Cystathionine beta-synthase inhibitor | 0.208 0.023 DBMET03411 0.208 0.023 DBMET03406 0.17 0.033 DBMET03405 0.135 0.048 DBMET03408 0.227 0.019 DBMET03407 | DBMET03407 | |
| 0.094 | 0.064 | 0.094 | DNA directed RNA polymerase inhibitor | |||
| 0.08 | 0.051 | 0.102 | Na+ K+ transporting ATPase inhibitor | 0.071 0.059 DBMET03411 0.09 0.04 DBMET03404 0.071 0.059 DBMET03406 0.066 0.064 DBMET03405 0.087 0.043 DBMET03408 0.091 0.04 DBMET03407 0.102 0.03 DBMET03409 0.09 0.041 DBMET03410 | DBMET03409 | |
| 0.108 | 0.08 | 0.108 | Beta amyloid protein antagonist | |||
| 0.064 | 0.036 | 0.105 | Androgen agonist | 0.084 0.022 DBMET03411 0.084 0.022 DBMET03406 0.072 0.029 DBMET03405 0.105 0.013 DBMET03407 0.098 0.015 DBMET03409 | DBMET03407 | |
| 0.142 | 0.116 | 0.206 | ATPase inhibitor | 0.154 0.095 DBMET03404 0.136 0.127 DBMET03405 0.206 0.033 DBMET03408 0.137 0.125 DBMET03410 | DBMET03408 | |
| 0.171 | 0.145 | 0.447 | Hypoglycemic | 0.177 0.138 DBMET03411 0.201 0.111 DBMET03404 0.177 0.138 DBMET03406 0.447 0.021 DBMET03408 0.2 0.112 DBMET03407 0.386 0.03 DBMET03410 | DBMET03408 | |
| 0.025 | 0.005 | 0.027 | Antibiotic Macrolide-like | 0.027 0.005 DBMET03404 | DBMET03404 | |
| 0.022 | 0.004 | 0.025 | Antibiotic Tetracycline-like | 0.02 0.004 DBMET03411 0.02 0.004 DBMET03404 0.02 0.004 DBMET03406 0.02 0.004 DBMET03405 0.017 0.006 DBMET03408 0.025 0.003 DBMET03407 0.018 0.005 DBMET03409 0.017 0.006 DBMET03410 | DBMET03407 | |
| 0.071 | 0.053 | 0.071 | Glycine receptor agonist | |||
| 0.128 | 0.114 | 0.128 | Heat shock protein 90 alpha antagonist | |||
| 0.066 | 0.054 | 0.116 | HIV-1 integrase inhibitor | 0.071 0.047 DBMET03411 0.071 0.047 DBMET03406 0.074 0.044 DBMET03405 0.085 0.035 DBMET03407 0.116 0.017 DBMET03409 | DBMET03409 | |
| 0.2 | 0.19 | 0.365 | Interleukin 2 agonist | 0.251 0.117 DBMET03404 0.199 0.192 DBMET03405 0.345 0.048 DBMET03408 0.203 0.184 DBMET03407 0.365 0.039 DBMET03410 | DBMET03410 | |
| 0.059 | 0.05 | 0.059 | Nitric oxide donor | |||
| 0.08 | 0.071 | 0.1 | Transcription factor NF kappa B stimulant | 0.081 0.067 DBMET03404 0.1 0.039 DBMET03408 0.096 0.044 DBMET03410 | DBMET03408 | |
| 0.111 | 0.111 | 0.168 | Neurotrophic factor | 0.168 0.045 DBMET03405 | DBMET03405 | |
| 0.114 | 0.129 | 0.158 | NOS3 expression enhancer | 0.158 0.064 DBMET03408 0.149 0.074 DBMET03410 | DBMET03408 | |
| 0.014 | 0.031 | 0.022 | Corticosteroid-like | 0.021 0.014 DBMET03408 0.022 0.014 DBMET03410 | DBMET03410 | |
| 0.075 | 0.092 | 0.085 | T cell inhibitor | 0.078 0.073 DBMET03404 0.085 0.048 DBMET03408 0.079 0.071 DBMET03410 | DBMET03408 | |
| 0.096 | 0.121 | 0.136 | NADPH oxidase inhibitor | 0.136 0.066 DBMET03405 0.11 0.097 DBMET03407 | DBMET03405 | |
| 0.079 | 0.105 | 0.134 | Estrogen receptor beta antagonist | 0.116 0.037 DBMET03411 0.116 0.037 DBMET03406 0.107 0.052 DBMET03405 0.134 0.021 DBMET03407 0.111 0.045 DBMET03409 | DBMET03407 | |
| 0.076 | 0.107 | 0.145 | Glutamate release inhibitor | 0.145 0.011 DBMET03411 0.098 0.046 DBMET03404 0.145 0.011 DBMET03406 0.116 0.025 DBMET03405 0.141 0.012 DBMET03408 0.116 0.025 DBMET03407 0.091 0.059 DBMET03410 | DBMET03406 | |
| 0.05 | 0.084 | 0.081 | Neuraminidase (influenza) inhibitor | 0.059 0.057 DBMET03404 0.061 0.052 DBMET03408 0.081 0.024 DBMET03409 0.062 0.049 DBMET03410 | DBMET03409 | |
| 0.103 | 0.141 | 0.138 | Papain-like protease (SARS coronavirus) inhibitor | 0.134 0.053 DBMET03411 0.134 0.053 DBMET03406 0.126 0.067 DBMET03405 0.138 0.047 DBMET03407 | DBMET03407 | |
| 0.012 | 0.052 | 0.028 | RNA-directed RNA polymerase stimulant | 0.026 0.024 DBMET03411 0.026 0.024 DBMET03406 0.028 0.022 DBMET03407 | DBMET03407 | |
| 0.158 | 0.199 | 0.203 | Transcription factor STAT3 inhibitor | 0.203 0.13 DBMET03405 | DBMET03405 | |
| 0.02 | 0.064 | 0.027 | Toll-Like receptor 4 agonist | 0.027 0.017 DBMET03408 0.026 0.019 DBMET03409 0.025 0.023 DBMET03410 | DBMET03408 | |
| 0.067 | 0.114 | 0.104 | Interleukin 5 antagonist | 0.104 0.037 DBMET03411 0.086 0.061 DBMET03404 0.104 0.037 DBMET03406 0.084 0.064 DBMET03405 0.093 0.051 DBMET03407 | DBMET03406 | |
| 0.035 | 0.085 | 0.068 | Neuraminidase inhibitor | 0.068 0.035 DBMET03409 | DBMET03409 | |
| 0.078 | 0.149 | 0.158 | Electron transport complex I inhibitor | 0.158 0.017 DBMET03411 0.109 0.065 DBMET03404 0.158 0.017 DBMET03406 0.143 0.025 DBMET03405 0.143 0.024 DBMET03407 | DBMET03406 | |
| 0.041 | 0.117 | 0.067 | Adenine nucleotide translocase inhibitor | 0.053 0.046 DBMET03408 0.067 0.018 DBMET03409 0.052 0.051 DBMET03410 | DBMET03409 | |
| 0.01 | 0.09 | 0.029 | Dopamine D1 agonist | 0.029 0.009 DBMET03409 | DBMET03409 | |
| 0.082 | 0.17 | 0.109 | Interleukin 1 antagonist | 0.109 0.107 DBMET03411 0.109 0.107 DBMET03406 | DBMET03406 | |
| 0.044 | 0.137 | 0.205 | CDC25A inhibitor | 0.089 0.035 DBMET03411 0.089 0.035 DBMET03406 0.075 0.049 DBMET03405 0.111 0.022 DBMET03407 0.205 0.006 DBMET03409 | DBMET03409 | |
| 0.013 | 0.106 | 0.278 | Estrogen agonist | 0.059 0.031 DBMET03411 0.059 0.031 DBMET03406 0.052 0.034 DBMET03408 0.091 0.02 DBMET03407 0.278 0.005 DBMET03409 0.043 0.04 DBMET03410 | DBMET03409 | |
| 0.02 | 0.114 | 0.062 | Aldose reductase inhibitor | 0.045 0.044 DBMET03411 0.045 0.044 DBMET03406 0.045 0.044 DBMET03405 0.054 0.036 DBMET03408 0.06 0.032 DBMET03407 0.062 0.031 DBMET03409 | DBMET03409 | |
| 0.005 | 0.103 | 0.146 | Estrogen receptor beta agonist | 0.048 0.019 DBMET03407 0.146 0.007 DBMET03409 | DBMET03409 | |
| 0.01 | 0.111 | 0.038 | Glucocorticoid antagonist | 0.038 0.02 DBMET03411 0.038 0.02 DBMET03406 0.035 0.021 DBMET03407 | DBMET03406 | |
| 0.012 | 0.12 | 0.041 | 1,3-Beta-glucan synthase inhibitor | 0.027 0.025 DBMET03404 0.027 0.025 DBMET03405 0.027 0.025 DBMET03408 0.029 0.018 DBMET03407 0.041 0.004 DBMET03409 0.029 0.017 DBMET03410 | DBMET03409 | |
| 0.004 | 0.125 | 0.061 | Estrogen receptor alpha agonist | 0.034 0.024 DBMET03411 0.034 0.024 DBMET03406 0.061 0.015 DBMET03407 0.048 0.018 DBMET03409 | DBMET03407 | |
| 0.032 | 0.153 | 0.103 | CDC25B inhibitor | 0.082 0.026 DBMET03411 0.082 0.026 DBMET03406 0.061 0.05 DBMET03405 0.103 0.015 DBMET03407 | DBMET03407 | |
| 0.047 | 0.169 | 0.09 | Antineoplastic alkaloid | 0.09 0.055 DBMET03411 0.09 0.055 DBMET03406 0.087 0.058 DBMET03405 | DBMET03406 | |
| 0.005 | 0.13 | 0.122 | Estrone sulfatase inhibitor | 0.021 0.015 DBMET03411 0.021 0.015 DBMET03406 0.029 0.011 DBMET03407 0.122 0.004 DBMET03409 | DBMET03409 | |
| 0.055 | 0.181 | 0.15 | Tubulin antagonist | 0.15 0.058 DBMET03411 0.15 0.058 DBMET03406 0.125 0.075 DBMET03405 | DBMET03406 | |
| 0.08 | 0.21 | 0.21 | Arachidonic acid antagonist | 0.199 0.034 DBMET03411 0.199 0.034 DBMET03406 0.17 0.065 DBMET03405 0.124 0.121 DBMET03408 0.21 0.024 DBMET03407 0.161 0.075 DBMET03409 | DBMET03407 | |
| 0.054 | 0.187 | 0.133 | DNA polymerase I inhibitor | 0.133 0.059 DBMET03408 0.12 0.068 DBMET03407 0.12 0.068 DBMET03410 | DBMET03408 | |
| 0.065 | 0.2 | 0.182 | Photosensitizer | 0.18 0.018 DBMET03411 0.18 0.018 DBMET03406 0.154 0.029 DBMET03405 0.179 0.018 DBMET03408 0.182 0.017 DBMET03407 0.098 0.093 DBMET03409 0.128 0.048 DBMET03410 | DBMET03407 | |
| 0.017 | 0.153 | 0.051 | Alpha tubulin antagonist | 0.051 0.04 DBMET03411 0.051 0.04 DBMET03406 0.05 0.04 DBMET03407 | DBMET03406 | |
| 0.004 | 0.143 | 0.014 | Prostacyclin agonist | 0.014 0.013 DBMET03405 | DBMET03405 | |
| 0.048 | 0.197 | 0.251 | Cholesterol synthesis inhibitor | 0.165 0.038 DBMET03411 0.165 0.038 DBMET03406 0.123 0.062 DBMET03405 0.104 0.082 DBMET03408 0.186 0.03 DBMET03407 0.251 0.018 DBMET03409 | DBMET03409 | |
| 0.012 | 0.166 | 0.067 | Beta tubulin antagonist | 0.067 0.036 DBMET03411 0.067 0.036 DBMET03406 0.052 0.045 DBMET03407 | DBMET03406 | |
| 0.039 | 0.205 | 0.066 | Heme oxygenase stimulant | 0.066 0.032 DBMET03407 | DBMET03407 | |
| 0.043 | 0.217 | 0.114 | UDP-glucose 4-epimerase inhibitor | 0.102 0.059 DBMET03408 0.114 0.048 DBMET03410 | DBMET03410 | |
| 0.076 | 0.254 | 0.272 | Interleukin antagonist | 0.246 0.063 DBMET03411 0.246 0.063 DBMET03406 0.196 0.086 DBMET03405 0.272 0.054 DBMET03407 | DBMET03407 | |
| 0.046 | 0.227 | 0.087 | Xanthine oxidase inhibitor | 0.087 0.076 DBMET03408 0.084 0.083 DBMET03407 | DBMET03408 | |
| 0.008 | 0.191 | 0.038 | Prostaglandin D2 agonist | 0.038 0.014 DBMET03411 0.038 0.014 DBMET03406 0.036 0.016 DBMET03405 0.037 0.015 DBMET03407 | DBMET03406 | |
| 0.024 | 0.212 | 0.065 | Factor IXa inhibitor | 0.065 0.023 DBMET03409 | DBMET03409 | |
| 0.071 | 0.263 | 0.242 | Sigma receptor agonist | 0.242 0.05 DBMET03411 0.242 0.05 DBMET03406 0.155 0.082 DBMET03405 0.132 0.101 DBMET03407 | DBMET03406 | |
| 0.087 | 0.282 | 0.236 | Neurotrophic factor enhancer | 0.184 0.094 DBMET03411 0.184 0.094 DBMET03406 0.174 0.106 DBMET03408 0.236 0.047 DBMET03407 0.158 0.126 DBMET03410 | DBMET03407 | |
| 0.032 | 0.229 | 0.098 | Glycine receptor antagonist | 0.098 0.034 DBMET03409 | DBMET03409 | |
| 0.062 | 0.27 | 0.304 | Cell wall synthesis inhibitor | 0.118 0.102 DBMET03411 0.123 0.095 DBMET03404 0.118 0.102 DBMET03406 0.174 0.044 DBMET03408 0.188 0.035 DBMET03407 0.304 0.01 DBMET03409 0.181 0.039 DBMET03410 | DBMET03409 | |
| 0.024 | 0.232 | 0.216 | Androgen antagonist | 0.171 0.017 DBMET03411 0.171 0.017 DBMET03406 0.121 0.033 DBMET03405 0.216 0.012 DBMET03407 0.082 0.063 DBMET03409 | DBMET03407 | |
| 0.009 | 0.218 | 0.047 | ATP citrate lysase inhibitor | 0.047 0.009 DBMET03407 | DBMET03407 | |
| 0.006 | 0.215 | 0.024 | Leukotriene B4 receptor 2 antagonist | 0.021 0.016 DBMET03408 0.024 0.013 DBMET03407 | DBMET03407 | |
| 0.106 | 0.316 | 0.472 | Cholesterol antagonist | 0.298 0.093 DBMET03411 0.298 0.093 DBMET03406 0.211 0.155 DBMET03405 0.423 0.045 DBMET03408 0.297 0.093 DBMET03407 0.472 0.037 DBMET03409 0.339 0.069 DBMET03410 | DBMET03409 | |
| 0.068 | 0.281 | 0.309 | Interleukin agonist | 0.251 0.078 DBMET03411 0.251 0.078 DBMET03406 0.224 0.099 DBMET03405 0.309 0.044 DBMET03408 0.246 0.081 DBMET03407 0.262 0.07 DBMET03410 | DBMET03408 | |
| 0.055 | 0.268 | 0.123 | Cell adhesion inhibitor | 0.123 0.063 DBMET03408 | DBMET03408 | |
| 0.118 | 0.337 | 0.347 | Sodium/bile acid cotransporter inhibitor | 0.347 0.041 DBMET03411 0.347 0.041 DBMET03406 0.321 0.061 DBMET03405 0.274 0.103 DBMET03408 0.34 0.047 DBMET03407 0.333 0.051 DBMET03409 0.239 0.14 DBMET03410 | DBMET03406 | |
| 0.006 | 0.234 | 0.04 | Sodium/glucose cotransporter 2 inhibitor | 0.04 0.008 DBMET03408 0.027 0.018 DBMET03410 | DBMET03408 | |
| 0.073 | 0.309 | 0.21 | Tumour necrosis factor alpha release inhibitor | 0.21 0.1 DBMET03411 0.155 0.152 DBMET03404 0.21 0.1 DBMET03406 0.205 0.105 DBMET03405 0.207 0.103 DBMET03408 0.18 0.126 DBMET03410 | DBMET03406 | |
| 0.07 | 0.31 | 0.151 | Adenylate cyclase stimulant | 0.134 0.093 DBMET03411 0.134 0.093 DBMET03406 0.13 0.102 DBMET03405 0.15 0.063 DBMET03407 0.151 0.061 DBMET03409 | DBMET03409 | |
| 0.027 | 0.267 | 0.173 | 5-Lipoxygenase inhibitor | 0.139 0.042 DBMET03411 0.139 0.042 DBMET03406 0.103 0.061 DBMET03405 0.173 0.03 DBMET03407 | DBMET03407 | |
| 0.061 | 0.306 | 0.183 | Hexokinase inhibitor | 0.183 0.047 DBMET03408 0.142 0.089 DBMET03407 | DBMET03408 | |
| 0.095 | 0.35 | 0.272 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.269 0.034 DBMET03411 0.269 0.034 DBMET03406 0.232 0.051 DBMET03405 0.193 0.078 DBMET03408 0.272 0.033 DBMET03407 | DBMET03407 | |
| 0.094 | 0.353 | 0.134 | CC chemokine 6 receptor antagonist | 0.134 0.057 DBMET03408 0.13 0.071 DBMET03410 | DBMET03408 | |
| 0.036 | 0.304 | 0.193 | Beta glucuronidase inhibitor | 0.193 0.014 DBMET03408 0.124 0.042 DBMET03410 | DBMET03408 | |
| 0.033 | 0.311 | 0.16 | AMP-activated protein kinase stimulant | 0.16 0.023 DBMET03408 0.112 0.056 DBMET03407 0.112 0.056 DBMET03410 | DBMET03408 | |
| 0.143 | 0.423 | 0.324 | 5 Hydroxytryptamine release inhibitor | 0.324 0.139 DBMET03411 0.324 0.139 DBMET03406 0.268 0.204 DBMET03405 0.278 0.191 DBMET03408 0.292 0.175 DBMET03407 | DBMET03406 | |
| 0.036 | 0.319 | 0.297 | Protein-tyrosine phosphatase inhibitor | 0.297 0.019 DBMET03409 | DBMET03409 | |
| 0.015 | 0.3 | 0.076 | Leukotriene B4 antagonist | 0.07 0.02 DBMET03411 0.07 0.02 DBMET03406 0.049 0.046 DBMET03405 0.063 0.024 DBMET03408 0.076 0.017 DBMET03407 0.076 0.017 DBMET03409 0.052 0.041 DBMET03410 | DBMET03409 | |
| 0.018 | 0.314 | 0.132 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.127 0.026 DBMET03411 0.127 0.026 DBMET03406 0.086 0.046 DBMET03405 0.132 0.025 DBMET03407 | DBMET03407 | |
| 0.006 | 0.32 | 0.028 | Sodium/glucose cotransporter inhibitor | 0.028 0.014 DBMET03408 | DBMET03408 | |
| 0.031 | 0.348 | 0.131 | Thrombolytic | 0.131 0.098 DBMET03408 | DBMET03408 | |
| 0.036 | 0.365 | 0.136 | Adenylate cyclase inhibitor | 0.136 0.055 DBMET03407 | DBMET03407 | |
| 0.036 | 0.373 | 0.136 | Antibacterial (Helicobacter pylori) | 0.128 0.071 DBMET03411 0.128 0.071 DBMET03406 0.136 0.06 DBMET03405 0.129 0.068 DBMET03407 | DBMET03405 | |
| 0.013 | 0.365 | 0.16 | Protein-tyrosine phosphatase 1B inhibitor | 0.16 0.042 DBMET03409 | DBMET03409 | |
| 0.046 | 0.399 | 0.294 | Platelet adhesion inhibitor | 0.294 0.036 DBMET03408 0.268 0.044 DBMET03409 0.201 0.07 DBMET03410 | DBMET03408 | |
| 0.03 | 0.393 | 0.102 | Alpha-N-acetylglucosaminidase inhibitor | 0.102 0.098 DBMET03407 0.101 0.1 DBMET03410 | DBMET03407 | |
| 0.032 | 0.405 | 0.081 | NADH dehydrogenase inhibitor | 0.081 0.073 DBMET03408 | DBMET03408 | |
| 0.004 | 0.384 | 0.065 | Dopamine D2 agonist | 0.065 0.019 DBMET03409 | DBMET03409 | |
| 0.024 | 0.404 | 0.107 | Sphingomyelinase inhibitor | 0.101 0.058 DBMET03411 0.101 0.058 DBMET03406 0.107 0.053 DBMET03407 | DBMET03407 | |
| 0.099 | 0.481 | 0.462 | Cyclophilin D inhibitor | 0.462 0.062 DBMET03408 0.263 0.198 DBMET03409 0.335 0.134 DBMET03410 | DBMET03408 | |
| 0.047 | 0.429 | 0.138 | Insulin secretagoues | 0.138 0.087 DBMET03408 | DBMET03408 | |
| 0.022 | 0.41 | 0.088 | Somatostatin 1 agonist | 0.088 0.043 DBMET03407 | DBMET03407 | |
| 0.023 | 0.43 | 0.176 | Anabolic | 0.137 0.026 DBMET03411 0.137 0.026 DBMET03406 0.111 0.049 DBMET03405 0.165 0.011 DBMET03407 0.176 0.008 DBMET03409 | DBMET03409 | |
| 0.016 | 0.427 | 0.094 | Carbonic anhydrase XIII inhibitor | 0.094 0.041 DBMET03409 | DBMET03409 | |
| 0.115 | 0.535 | 0.509 | Calcium channel L-type activator | 0.5 0.028 DBMET03411 0.313 0.146 DBMET03404 0.5 0.028 DBMET03406 0.446 0.053 DBMET03405 0.297 0.16 DBMET03408 0.509 0.024 DBMET03407 0.393 0.086 DBMET03409 0.342 0.123 DBMET03410 | DBMET03407 | |
| 0.005 | 0.428 | 0.074 | Aromatase inhibitor | 0.065 0.038 DBMET03411 0.065 0.038 DBMET03406 0.074 0.031 DBMET03407 | DBMET03407 | |
| 0.064 | 0.501 | 0.324 | Histamine release inhibitor | 0.226 0.175 DBMET03411 0.226 0.175 DBMET03406 0.324 0.111 DBMET03408 0.267 0.143 DBMET03407 0.206 0.195 DBMET03410 | DBMET03408 | |
| 0.023 | 0.464 | 0.14 | Estrogen receptor alpha antagonist | 0.108 0.023 DBMET03411 0.108 0.023 DBMET03406 0.08 0.048 DBMET03405 0.14 0.013 DBMET03407 0.07 0.067 DBMET03409 | DBMET03407 | |
| 0.032 | 0.474 | 0.158 | Platelet antagonist | 0.158 0.137 DBMET03408 | DBMET03408 | |
| 0.01 | 0.465 | 0.035 | Purinergic P2Y2 antagonist | 0.035 0.021 DBMET03409 | DBMET03409 | |
| 0.044 | 0.505 | 0.141 | Phospholipase C inhibitor | 0.141 0.126 DBMET03409 | DBMET03409 | |
| 0.005 | 0.467 | 0.111 | Potassium channel Kv1.3 blocker | 0.111 0.007 DBMET03411 0.111 0.007 DBMET03406 0.058 0.022 DBMET03405 0.059 0.021 DBMET03407 | DBMET03406 | |
| 0.073 | 0.537 | 0.507 | Calcium channel activator | 0.507 0.005 DBMET03411 0.507 0.005 DBMET03406 0.454 0.01 DBMET03405 0.309 0.083 DBMET03408 0.441 0.013 DBMET03407 0.316 0.076 DBMET03409 | DBMET03406 | |
| 0.025 | 0.515 | 0.165 | Hypolipemic | 0.146 0.141 DBMET03405 0.165 0.122 DBMET03408 | DBMET03408 | |
| 0.018 | 0.518 | 0.073 | Glutamate dehydrogenase inhibitor | 0.073 0.053 DBMET03407 | DBMET03407 | |
| 0.09 | 0.598 | 0.231 | 5 Hydroxytryptamine uptake stimulant | 0.221 0.116 DBMET03411 0.221 0.116 DBMET03406 0.194 0.164 DBMET03405 0.231 0.102 DBMET03407 | DBMET03407 | |
| 0.03 | 0.543 | 0.289 | Lipoxygenase inhibitor | 0.285 0.079 DBMET03411 0.285 0.079 DBMET03406 0.218 0.123 DBMET03405 0.289 0.077 DBMET03407 | DBMET03407 | |
| 0.021 | 0.546 | 0.216 | Triose-phosphate isomerase inhibitor | 0.098 0.05 DBMET03408 0.093 0.056 DBMET03407 0.216 0.009 DBMET03409 0.108 0.04 DBMET03410 | DBMET03409 | |
| 0.032 | 0.582 | 0.316 | Cyclic AMP phosphodiesterase inhibitor | 0.286 0.048 DBMET03411 0.286 0.048 DBMET03406 0.214 0.084 DBMET03405 0.316 0.036 DBMET03408 0.265 0.057 DBMET03407 0.174 0.117 DBMET03410 | DBMET03408 | |
| 0.004 | 0.561 | 0.071 | Leukotriene antagonist | 0.062 0.048 DBMET03411 0.062 0.048 DBMET03406 0.071 0.039 DBMET03407 | DBMET03407 | |
| 0.01 | 0.57 | 0.045 | Vanilloid 3 antagonist | 0.045 0.013 DBMET03411 0.045 0.013 DBMET03406 | DBMET03406 | |
| 0.021 | 0.583 | 0.111 | Acetylcholine release stimulant | 0.111 0.064 DBMET03409 | DBMET03409 | |
| 0.016 | 0.58 | 0.114 | Keratolytic | 0.114 0.024 DBMET03411 0.114 0.024 DBMET03406 0.086 0.042 DBMET03405 0.112 0.024 DBMET03407 | DBMET03406 | |
| 0.02 | 0.592 | 0.093 | Carbonic anhydrase III inhibitor | 0.093 0.071 DBMET03407 | DBMET03407 | |
| 0.043 | 0.623 | 0.268 | Vasodilator, coronary | 0.268 0.116 DBMET03408 | DBMET03408 | |
| 0.01 | 0.597 | 0.062 | Fatty acid synthase inhibitor | 0.062 0.033 DBMET03407 | DBMET03407 | |
| 0.023 | 0.612 | 0.657 | Aldehyde oxidase inhibitor | 0.6 0.019 DBMET03411 0.6 0.019 DBMET03406 0.285 0.07 DBMET03405 0.657 0.012 DBMET03407 | DBMET03407 | |
| 0.018 | 0.612 | 0.358 | Dual specificity phosphatase inhibitor | 0.127 0.125 DBMET03411 0.127 0.125 DBMET03406 0.142 0.103 DBMET03407 0.358 0.02 DBMET03409 | DBMET03409 | |
| 0.002 | 0.613 | 0.074 | Estradiol 17 beta-dehydrogenase inhibitor | 0.055 0.022 DBMET03411 0.055 0.022 DBMET03406 0.074 0.014 DBMET03407 | DBMET03407 | |
| 0.018 | 0.632 | 0.111 | Aldehyde dehydrogenase inhibitor | 0.111 0.081 DBMET03407 | DBMET03407 | |
| 0.017 | 0.639 | 0.135 | DOPA decarboxylase inhibitor | 0.098 0.08 DBMET03411 0.098 0.08 DBMET03406 0.135 0.031 DBMET03407 | DBMET03407 | |
| 0.055 | 0.701 | 0.225 | Tyrosine 3 hydroxylase inhibitor | 0.203 0.131 DBMET03411 0.203 0.131 DBMET03406 0.225 0.096 DBMET03407 | DBMET03407 | |
| 0.037 | 0.685 | 0.244 | Vasodilator, peripheral | 0.244 0.131 DBMET03411 0.244 0.131 DBMET03406 0.202 0.174 DBMET03407 | DBMET03406 | |
| 0.011 | 0.666 | 0.084 | Interleukin 1 beta converting enzyme inhibitor | 0.084 0.082 DBMET03411 0.084 0.082 DBMET03406 | DBMET03406 | |
| 0.008 | 0.665 | 0.069 | Pregnane X receptor antagonist | 0.069 0.015 DBMET03411 0.069 0.015 DBMET03406 0.056 0.04 DBMET03405 0.065 0.021 DBMET03407 | DBMET03406 | |
| 0.007 | 0.674 | 0.056 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.056 0.034 DBMET03407 | DBMET03407 | |
| 0.011 | 0.679 | 0.197 | Insulin sensitizer | 0.176 0.099 DBMET03411 0.176 0.099 DBMET03406 0.197 0.076 DBMET03407 | DBMET03407 | |
| 0.011 | 0.696 | 0.23 | Spasmolytic | 0.215 0.108 DBMET03411 0.215 0.108 DBMET03406 0.172 0.143 DBMET03408 0.23 0.1 DBMET03407 | DBMET03407 | |
| 0.018 | 0.718 | 0.352 | Peroxidase inhibitor | 0.18 0.065 DBMET03411 0.18 0.065 DBMET03406 0.352 0.028 DBMET03407 | DBMET03407 | |
| 0.014 | 0.72 | 0.14 | Succinate dehydrogenase inhibitor | 0.14 0.133 DBMET03407 | DBMET03407 | |
| 0.005 | 0.714 | 0.227 | Diuretic | 0.227 0.035 DBMET03409 | DBMET03409 | |
| 0.004 | 0.718 | 0.071 | Glutamate decarboxylase inhibitor | 0.071 0.053 DBMET03407 | DBMET03407 | |
| 0.004 | 0.724 | 0.067 | Beta adrenoreceptor antagonist | 0.067 0.043 DBMET03411 0.067 0.043 DBMET03406 0.06 0.056 DBMET03405 | DBMET03406 | |
| 0.008 | 0.734 | 0.161 | Cathepsin G inhibitor | 0.071 0.052 DBMET03411 0.071 0.052 DBMET03406 0.161 0.019 DBMET03409 | DBMET03409 | |
| 0.008 | 0.74 | 0.157 | Creatine kinase inhibitor | 0.157 0.021 DBMET03407 | DBMET03407 | |
| 0.014 | 0.756 | 0.096 | HIV-1 integrase (Overall Integration) inhibitor | 0.096 0.058 DBMET03407 | DBMET03407 | |
| 0.008 | 0.762 | 0.284 | Anticoagulant | 0.284 0.031 DBMET03409 | DBMET03409 | |
| 0.004 | 0.775 | 0.065 | Phenylalanine 4-hydroxylase inhibitor | 0.065 0.051 DBMET03407 | DBMET03407 | |
| 0.008 | 0.793 | 0.22 | Dual specificity phosphatase 3 inhibitor | 0.22 0.051 DBMET03409 | DBMET03409 | |
| 0.016 | 0.808 | 0.121 | MAP3K9 inhibitor | 0.119 0.117 DBMET03411 0.119 0.117 DBMET03406 0.121 0.112 DBMET03407 | DBMET03407 | |
| 0.005 | 0.801 | 0.054 | Elastase inhibitor | 0.054 0.035 DBMET03409 | DBMET03409 | |
| 0.014 | 0.819 | 0.154 | Nav1.4 sodium channel blocker | 0.092 0.089 DBMET03411 0.092 0.089 DBMET03406 0.105 0.069 DBMET03407 0.154 0.032 DBMET03409 | DBMET03409 | |
| 0.01 | 0.821 | 0.201 | Hemostatic | 0.201 0.032 DBMET03409 | DBMET03409 | |
| 0.007 | 0.82 | 0.098 | Prolactin inhibitor | 0.098 0.057 DBMET03407 | DBMET03407 | |
| 0.005 | 0.838 | 0.097 | Bronchodilator | 0.097 0.068 DBMET03411 0.097 0.068 DBMET03406 | DBMET03406 | |
| 0.02 | 0.862 | 0.259 | GABA C receptor rho-3 antagonist | 0.259 0.146 DBMET03407 | DBMET03407 | |
| 0.008 | 0.852 | 0.138 | Antipruritic | 0.138 0.11 DBMET03407 | DBMET03407 | |
| 0.002 | 0.886 | 0.106 | NMDA receptor antagonist | 0.084 0.061 DBMET03407 0.106 0.044 DBMET03409 | DBMET03409 | |
| 0.002 | 0.896 | 0.048 | Leukocyte elastase inhibitor | 0.048 0.025 DBMET03409 | DBMET03409 | |
| 0.006 | 0.905 | 0.494 | Cholecystokinin B agonist | 0.494 0.002 DBMET03409 | DBMET03409 | |
| 0.002 | 0.923 | 0.223 | Cholecystokinin A agonist | 0.223 0.003 DBMET03409 | DBMET03409 | |
| 0.003 | 0.926 | 0.037 | NMDA 2D receptor antagonist | 0.037 0.011 DBMET03409 | DBMET03409 | |
| 0.003 | 0.927 | 0.213 | NMDA 2B receptor antagonist | 0.213 0.005 DBMET03409 | DBMET03409 | |
| 0.002 | 0.929 | 0.281 | Cholecystokinin agonist | 0.281 0.003 DBMET03409 | DBMET03409 | |
| 0.002 | 0.937 | 0.065 | Cholecystokinin B antagonist | 0.065 0.008 DBMET03409 | DBMET03409 | |
| 0.002 | 0.949 | 0.082 | Cholecystokinin antagonist | 0.082 0.011 DBMET03409 | DBMET03409 | |
| 0.001 | 0.95 | 0.096 | NMDA 2 receptor antagonist | 0.096 0.034 DBMET03409 | DBMET03409 | |
| 0.002 | 0.975 | 0.111 | Cholecystokinin A antagonist | 0.111 0.007 DBMET03409 | DBMET03409 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |